Processing

Please wait...

Settings

Settings

1. WO2014205300 - LECTIN-LIKE OXIDIZED LDL RECEPTOR1 ANTIBODIES AND METHODS OF USE

Publication Number WO/2014/205300
Publication Date 24.12.2014
International Application No. PCT/US2014/043315
International Filing Date 20.06.2014
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
C07K 16/28 (2006.01)
CPC
A61K 2039/505
A61K 39/3955
A61K 45/06
A61K 9/0019
A61P 9/04
A61P 9/08
Applicants
  • NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-Basel, CH (AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BE, BF, BG, BH, BJ, BN, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CL, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IR, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, ME, MG, MK, ML, MN, MR, MT, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SI, SK, SL, SM, SN, ST, SV, SY, SZ, TD, TG, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW)
  • HELDWEIN, Kurt Alex [US/US]; US (US)
  • SPLAWSKI, Igor [PL/US]; US (US)
  • BROGDON, Jennifer [US/US]; US (US)
  • GOLDSTEIN, Joshua [US/US]; US (US)
  • DOLE, William [US/US]; US (US)
  • TRAUGER, John [US/US]; US (US)
  • ZHANG, Chonghui [CN/US]; US (US)
Inventors
  • HELDWEIN, Kurt Alex; US
  • SPLAWSKI, Igor; US
  • BROGDON, Jennifer; US
  • GOLDSTEIN, Joshua; US
  • DOLE, William; US
  • TRAUGER, John; US
  • ZHANG, Chonghui; US
Common Representative
  • NOVARTIS AG; Lichtstrasse 35 CH-Basel, CH
Priority Data
61/837,77621.06.2013US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) LECTIN-LIKE OXIDIZED LDL RECEPTOR1 ANTIBODIES AND METHODS OF USE
(FR) ANTICORPS ANTI-RÉCEPTEUR1 DE TYPE LECTINE DES LDL OXYDÉES ET PROCÉDÉS D'UTILISATION
Abstract
(EN)
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as "LOX-1"), and pharmaceutical compositions and methods of treatment comprising the same.
(FR)
La présente invention concerne des anticorps monoclonaux se liant au récepteur 1 de type lectine des LDL oxydées (lipoprotéine de basse densité) (ci-après parfois désigné par « LOX-1 ») humain, ainsi que des compositions pharmaceutiques et des procédés de traitement l'utilisant.
Also published as
CL2015-3642
CO15301138
CRCR2015-000668
ECIEPI-2016-2319
IDIDP00201600070
IL243176
IR139450140003010441
MA38715
UAa201512743
Latest bibliographic data on file with the International Bureau